Table 1 Indications and characteristics of patients (n = 86)
Indications | Number (%) (SD) |
|---|---|
Dysfunctional bleeding | 37 (43) |
Pelvic pain | 14 (16.3) |
Dysmenorrhea | 2 (2.3) |
Pelvic mass | 8 (9.3) |
Protective surgery | 9 (10.5) |
Atypical hyperplasia | 12 (14) |
CIN1 (+ mild hyperplasia) | 4 (4.6) |
Known fibroids | 20 (23.2) |
Total | 86 |
Patients characteristics | Data |
Age | 52.2 (± 11) |
BMI | 28.2 (± 7) |
Pre-menopause | 53 (61.6) |
Post-menopause | 33 (38.4) |
Nullipara | 17 (19.8) |
One para | 18 (20.9) |
Multipara | 51 (59.3) |
ASA | |
1 | 47 (54.7) |
2 | 37 (43) |
3 | 2 (2.3) |
4 | 0 |
Surgical history | |
Pelvic surgery | 23 (26.7) |
Vaginal | 5 (5.8) |
Paramedian incision | 12 (13.9) |
Pfannensteil | 20 (23.2) |
Midline laparotomy | 3 (3.5) |
Laparoscopy/ies | 37 (43) |
Medical history | |
Hypothyroid | 9 (10.5) |
HPN | 16 (18.6) |
DM | 1 (1.2) |
Anaemia | 6 (7) |
Non-gynaecological chemo/radiotherapy | 14 (16.3) |
Breast cancer | 9 (10.5) |
Smoker | 2 (2.3) |
Asthma | 11 (12.8) |
Anticoagulant/antiplatelet | 7 (8.1) |